Abstract
Pharmacotherapy considerations are often a concern for transgender individuals who are living with human immunodeficiency virus (HIV) due to concerns for drug–drug interactions between their hormone and antiretroviral therapies. Many of the first-line therapies offered to patients for the management of HIV have reduced concerns for safety, resistance, and drug–drug interactions. In this review, we highlight common medications and important considerations for caring for transgender people living with HIV.
| Original language | English |
|---|---|
| Pages (from-to) | 299-314 |
| Number of pages | 16 |
| Journal | Pharmacotherapy |
| Volume | 41 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 2021 |
Bibliographical note
© 2021 Pharmacotherapy Publications, Inc.ASJC Scopus Subject Areas
- Pharmacology (medical)
Keywords
- antiretroviral therapy
- hormone therapy
- human immunodeficiency virus
- transgender
- Drug Interactions
- Transgender Persons
- Humans
- Female
- Male
- HIV Infections/drug therapy
Disciplines
- Medical Pharmacology
Fingerprint
Dive into the research topics of 'Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS